Related Experiment Videos
Sordaricin antifungal agents.
Claude A Quesnelle1, Patrice Gill, Marco Dodier
1Bristol-Myers Squibb Pharmaceutical Research Institute, 100, boul. de l'Industrie, Candiac, Québec, Canada J5R 1J1. claude.quesnelle@bms.com
Bioorganic & Medicinal Chemistry Letters
|February 5, 2003
Summary
New sordaricin derivatives were synthesized and tested for antifungal activity. These compounds show potential for inhibiting fungal growth, offering new avenues in antifungal drug discovery.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Mycology
Background:
- Sordaricin is a natural product with known biological activities.
- Developing novel antifungal agents is crucial due to rising resistance.
- Exploring structural modifications of existing compounds can lead to improved efficacy.
Purpose of the Study:
- To synthesize novel sordaricin derivatives.
- To evaluate the antifungal activity of these new compounds.
- To investigate structure-activity relationships for fungal growth inhibition.
Main Methods:
- Organometallic addition reactions were employed for synthesis.
- Fully protected sordaricin aldehyde served as the starting material.
- Fungal growth inhibition assays were performed to assess activity.
Main Results:
- A series of homologated sordaricin, ether, and ester derivatives were successfully synthesized.
- Structural rearrangement products were identified upon oxidation.
- The synthesized compounds demonstrated varying degrees of fungal growth inhibition.
Conclusions:
- The synthesized sordaricin derivatives represent a promising class of potential antifungal agents.
- Further research into these compounds could lead to the development of new antifungal therapies.
- The study provides valuable insights into the antifungal potential of sordaricin analogs.